Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
The Journal of Allergy and Clinical Immunology|September 19, 2003
Antacid medication inhibits digestion of dietary proteins and causes food allergy: a fish allergy model in BALB/c miceEva Untersmayr, Isabella Schöll, Ines Swoboda, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 27, 2026
Berotralstat and Health-Related Quality of Life in Hereditary Angioedema: Pooled Analysis of the APeX-2 and APeX-J TrialsTeresa Caballero, Sorena Kiani-Alikhan, Douglas T Johnston, et al.
Allergy, Asthma & Immunology Research|July 2, 2021
Autoimmune Diseases Are Linked to Type IIb Autoimmune Chronic Spontaneous UrticariaPavel Kolkhir, Sabine Altrichter, Riccardo Asero, et al.
The Journal of Allergy and Clinical Immunology|May 20, 2023
Single-cell RNA sequencing defines disease-specific differences between chronic nodular prurigo and atopic dermatitisNatalia Alkon, Frank P Assen, Tamara Arnoldner, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 9, 2025
Long-term safety and efficacy of once-daily berotralstat in patients with hereditary angioedema: APeX-S final resultsHenriette Farkas, Jonny G Peter, Marcin Stobiecki, et al.
Revista Alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)|October 2, 2025
[Effectiveness and safety of Lanadelumab according to disease activity: pooled analysis of EMPOWER/ENABLE]Inmaculada Martinez-Saguer, Andrea Zanichelli, Emel Aygören-Pürsün, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 27, 2025
Oral berotralstat for hereditary angioedema prophylaxis in patients aged 2 to <12 years: APeX-P interim resultsJolanta Bernatoniene, Mélisande Bourgoin-Heck, Mauro Cancian, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 20, 2023
Once-Daily Oral Berotralstat for Long-Term Prophylaxis of Hereditary Angioedema: The Open-Label Extension of the APeX-2 Randomized TrialSorena Kiani-Alikhan, Richard Gower, Timothy Craig, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 6, 2025
Lanadelumab's impact on hereditary angioedema control and quality of life across disease activity subgroups: Real-world evidenceAndrea Zanichelli, Walter A Wuillemin, Emel Aygören-Pürsün, et al.
Allergy|June 23, 2019
Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST StudyNicole Schoepke, Riccardo Asero, André Ellrich, et al.
Pageof 6